Ditchcarbon
  • Contact
  1. Organizations
  2. Stallergenes Greer Ltd
Public Profile
Pharmaceutical Preparation Manufacturing
GB
updated 2 months ago

Stallergenes Greer Ltd Sustainability Profile

Company website

Stallergenes Greer Ltd, a leading player in the immunotherapy industry, is headquartered in Great Britain and operates extensively across Europe and North America. Founded in 2014 through the merger of Stallergenes and Greer Laboratories, the company has quickly established itself as a pioneer in allergy treatment solutions. Specialising in allergen immunotherapy, Stallergenes Greer offers a range of innovative products, including sublingual and injectable therapies, designed to provide long-term relief from allergic conditions. Their commitment to research and development has led to significant advancements in personalised treatment options, setting them apart in a competitive market. With a strong focus on patient-centric care, Stallergenes Greer Ltd has achieved notable recognition for its contributions to allergy management, solidifying its position as a trusted name in the field.

DitchCarbon Score

How does Stallergenes Greer Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

26

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Stallergenes Greer Ltd's score of 26 is lower than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.

42%

Let us know if this data was useful to you

Stallergenes Greer Ltd's reported carbon emissions

Stallergenes Greer Ltd, headquartered in Great Britain, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges available at this time. As a result, the company appears to be in the early stages of establishing its climate commitments and emissions reduction strategies. Without specific data or targets, it is challenging to assess their current environmental impact or future commitments in relation to industry standards. In the context of the broader industry, many companies are increasingly adopting Science-Based Targets Initiative (SBTi) guidelines and committing to net-zero emissions. However, Stallergenes Greer Ltd has not yet disclosed any such initiatives or commitments.

How Carbon Intensive is Stallergenes Greer Ltd's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Stallergenes Greer Ltd's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Stallergenes Greer Ltd's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Stallergenes Greer Ltd is in GB, which has a very low grid carbon intensity relative to other regions.

Stallergenes Greer Ltd's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Stallergenes Greer Ltd has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Stallergenes Greer Ltd's Emissions with Industry Peers

Viatris

US
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 17 days ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Vimian

SE
•
Health and social work services (85)
Updated 4 days ago

Sanofi

FR
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Alk

DK
•
Pharmaceutical Preparation Manufacturing
Updated about 3 hours ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251119.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy